Logo image of WELL-DB.CA

WELL HEALTH TECHNOLOGIES (WELL-DB.CA) Stock Overview

Canada - TSX:WELL-DB - CA94947LAC69

100.25 CAD
-0.25 (-0.25%)
Last: 10/1/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to WELL-DB. WELL-DB was compared to 15 industry peers in the Health Care Providers & Services industry. The financial health of WELL-DB is average, but there are quite some concerns on its profitability. WELL-DB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

WELL-DB had negative earnings in the past year.
WELL-DB had a positive operating cash flow in the past year.
In multiple years WELL-DB reported negative net income over the last 5 years.
Of the past 5 years WELL-DB 4 years had a positive operating cash flow.
WELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFWELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.37%, WELL-DB is doing worse than 66.67% of the companies in the same industry.
WELL-DB's Return On Equity of -15.57% is on the low side compared to the rest of the industry. WELL-DB is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
ROA -6.37%
ROE -15.57%
ROIC N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
WELL-DB.CA Yearly ROA, ROE, ROICWELL-DB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

WELL-DB has a Gross Margin (39.21%) which is comparable to the rest of the industry.
WELL-DB's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for WELL-DB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
WELL-DB.CA Yearly Profit, Operating, Gross MarginsWELL-DB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

4

2. Health

2.1 Basic Checks

WELL-DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WELL-DB has been increased compared to 1 year ago.
WELL-DB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, WELL-DB has an improved debt to assets ratio.
WELL-DB.CA Yearly Shares OutstandingWELL-DB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
WELL-DB.CA Yearly Total Debt VS Total AssetsWELL-DB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 13.26 indicates that WELL-DB is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 13.26, WELL-DB belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
WELL-DB has a Debt/Equity ratio of 0.68. This is a neutral value indicating WELL-DB is somewhat dependend on debt financing.
The Debt to Equity ratio of WELL-DB (0.68) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 13.26
ROIC/WACCN/A
WACC8.02%
WELL-DB.CA Yearly LT Debt VS Equity VS FCFWELL-DB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

WELL-DB has a Current Ratio of 0.93. This is a bad value and indicates that WELL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
WELL-DB has a better Current ratio (0.93) than 66.67% of its industry peers.
WELL-DB has a Quick Ratio of 0.93. This is a bad value and indicates that WELL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.92, WELL-DB is doing good in the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.92
WELL-DB.CA Yearly Current Assets VS Current LiabilitesWELL-DB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for WELL-DB have decreased strongly by -221.43% in the last year.
Looking at the last year, WELL-DB shows a very strong growth in Revenue. The Revenue has grown by 20.36%.
The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%

3.2 Future

The Earnings Per Share is expected to grow by 15.87% on average over the next years. This is quite good.
WELL-DB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.88% yearly.
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y15.88%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WELL-DB.CA Yearly Revenue VS EstimatesWELL-DB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL-DB.CA Yearly EPS VS EstimatesWELL-DB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 -0.2 0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WELL-DB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 330.92 indicates a quite expensive valuation of WELL-DB.
WELL-DB's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.29. WELL-DB is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 330.92
WELL-DB.CA Price Earnings VS Forward Price EarningsWELL-DB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, WELL-DB is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 382.79
WELL-DB.CA Per share dataWELL-DB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
WELL-DB's earnings are expected to grow with 34.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.11%
EPS Next 3Y34.36%

More info and screens

0

5. Dividend

5.1 Amount

WELL-DB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WELL HEALTH TECHNOLOGIES

TSX:WELL-DB (10/1/2025, 7:00:00 PM)

100.25

-0.25 (-0.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners5.81%
Inst Owner ChangeN/A
Ins Owners22.59%
Ins Owner ChangeN/A
Market Cap25.44B
Analysts81
Price Target171.45 (71.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-368.63%
Min EPS beat(2)-696.08%
Max EPS beat(2)-41.18%
EPS beat(4)0
Avg EPS beat(4)-1069.61%
Min EPS beat(4)-3335.29%
Max EPS beat(4)-41.18%
EPS beat(8)2
Avg EPS beat(8)1698.56%
EPS beat(12)3
Avg EPS beat(12)1044.26%
EPS beat(16)3
Avg EPS beat(16)671.21%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)1.59%
Revenue beat(4)1
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)-0.37%
Revenue beat(16)10
Avg Revenue beat(16)0.69%
PT rev (1m)6.3%
PT rev (3m)-13.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)191.38%
EPS NY rev (1m)697.61%
EPS NY rev (3m)3.87%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)28.01%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 330.92
P/S 23.21
P/FCF N/A
P/OCF 5489.09
P/B 30.79
P/tB N/A
EV/EBITDA 382.79
EPS(TTM)-0.51
EYN/A
EPS(NY)0.3
Fwd EY0.3%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.02%
SpS4.32
BVpS3.26
TBVpS-2.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.37%
ROE -15.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.21%
FCFM N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score2
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 8.34
Cap/Depr 25.5%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion 6.83%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.92
Altman-Z 13.26
F-Score2
WACC8.02%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y15.88%
EBIT growth 1Y-144.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year286.51%
EBIT Next 3Y64.16%
EBIT Next 5Y41.94%
FCF growth 1Y-124.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.87%
OCF growth 3Y-22.85%
OCF growth 5YN/A